Literature DB >> 30317061

Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease.

Neha J Pagidipati1, Daniel W Mudrick2, Karen Chiswell3, Amanda Brucker4, Eric D Peterson3, Pamela S Douglas3.   

Abstract

BACKGROUND: Patients with nonobstructive coronary artery disease (CAD) have worse outcomes compared with those without CAD; however, few studies have compared the intermediate- and long-term impact of CAD severity as a function of patient sex.
METHODS: We evaluated 5-year and long-term all-cause mortality of women and men undergoing elective coronary angiography at a single center by degree of CAD: no CAD (1%-24% stenosis), nonobstructive CAD (25%-69% epicardial stenosis or 25%-49% left main stenosis), or obstructive CAD (epicardial stenosis ≥70% or left main stenosis ≥50%), both overall and after adjusting for baseline clinical risk factors using Cox proportional-hazards models.
RESULTS: Between January 1986 and July 2010, 8,766 women and 11,638 men underwent angiography and were followed for a median of 9.2 years. The majority (67%) of women had no CAD or nonobstructive CAD, whereas the majority of men had obstructive CAD (56%, P < .001). In both sexes, increasing CAD was associated with increased 5-year risk of mortality. Risk-adjusted hazard ratios (vs no CAD) for women were 1.36 (95% CI, 1.16-1.60) and 1.86 (1.61-2.16) for nonobstructive and obstructive CAD, respectively; corresponding hazard ratios for men were 1.24 (1.06-1.45) and 1.38 (1.20-1.59). After risk adjustment, 5-year mortality risk was higher in men than in women at all levels of CAD severity. The relationships between severity of CAD and mortality risk during long-term follow-up in women and men were similar to the 5-year relationships above.
CONCLUSIONS: Although women undergoing elective catheterization have less severe CAD than men, nonobstructive CAD is prevalent in both sexes and carries a worse prognosis than no CAD. These data suggest a need for further investigation to establish optimal therapies for this at-risk group of patients with nonobstructive CAD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30317061      PMCID: PMC6294713          DOI: 10.1016/j.ahj.2018.09.014

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  20 in total

1.  Nonobstructive coronary artery disease and risk of myocardial infarction.

Authors:  Thomas M Maddox; Maggie A Stanislawski; Gary K Grunwald; Steven M Bradley; P Michael Ho; Thomas T Tsai; Manesh R Patel; Amneet Sandhu; Javier Valle; David J Magid; Benjamin Leon; Deepak L Bhatt; Stephan D Fihn; John S Rumsfeld
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease.

Authors:  James K Min; Allison Dunning; Fay Y Lin; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Victor Cheng; Kavitha Chinnaiyan; Benjamin J W Chow; Augustin Delago; Martin Hadamitzky; Joerg Hausleiter; Philipp Kaufmann; Erica Maffei; Gilbert Raff; Leslee J Shaw; Todd Villines; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2011-08-16       Impact factor: 24.094

Review 3.  Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.

Authors:  Carl J Pepine; Keith C Ferdinand; Leslee J Shaw; Kelly Ann Light-McGroary; Rashmee U Shah; Martha Gulati; Claire Duvernoy; Mary Norine Walsh; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2015-10-27       Impact factor: 24.094

4.  Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry.

Authors:  Joshua Schulman-Marcus; Bríain Ó Hartaigh; Heidi Gransar; Fay Lin; Valentina Valenti; Iksung Cho; Daniel Berman; Tracy Callister; Augustin DeLago; Martin Hadamitzky; Joerg Hausleiter; Mouaz Al-Mallah; Matthew Budoff; Philipp Kaufmann; Stephan Achenbach; Gilbert Raff; Kavitha Chinnaiyan; Filippo Cademartiri; Erica Maffei; Todd Villines; Yong-Jin Kim; Jonathon Leipsic; Gudrun Feuchtner; Ronen Rubinshtein; Gianluca Pontone; Daniele Andreini; Hugo Marques; Leslee Shaw; James K Min
Journal:  JACC Cardiovasc Imaging       Date:  2016-04

5.  Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study.

Authors:  Jonathon Leipsic; Carolyn M Taylor; Heidi Gransar; Leslee J Shaw; Amir Ahmadi; Angus Thompson; Karin Humphries; Daniel S Berman; Jörg Hausleiter; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Fillippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Benjamin J W Chow; Ricardo C Cury; Augustin J Delago; Allison L Dunning; Gudrun M Feuchtner; Martin Hadamitzky; Philipp A Kaufmann; Fay Y Lin; Kavitha M Chinnaiyan; Erica Maffei; Gilbert L Raff; Todd C Villines; Millie J Gomez; James K Min
Journal:  Radiology       Date:  2014-07-15       Impact factor: 11.105

6.  Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis.

Authors:  Leslee J Shaw; James K Min; Jagat Narula; Fay Lin; C Noel Bairey-Merz; Tracy Q Callister; Daniel S Berman
Journal:  Circ Cardiovasc Imaging       Date:  2010-05-19       Impact factor: 7.792

7.  Prognostic value of coronary vessel dominance in relation to significant coronary artery disease determined with non-invasive computed tomography coronary angiography.

Authors:  Caroline E Veltman; Fleur R de Graaf; Joanne D Schuijf; Jacob M van Werkhoven; J Wouter Jukema; Philipp A Kaufmann; Aju P Pazhenkottil; Lucia J Kroft; Eric Boersma; Jeroen J Bax; Martin J Schalij; Ernst E van der Wall
Journal:  Eur Heart J       Date:  2012-03-04       Impact factor: 29.983

8.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

9.  Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.

Authors:  Barry Sharaf; Todd Wood; Leslee Shaw; B Delia Johnson; Sheryl Kelsey; R David Anderson; Carl J Pepine; C Noel Bairey Merz
Journal:  Am Heart J       Date:  2013-05-02       Impact factor: 4.749

10.  Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography.

Authors:  Matthew P Ostrom; Ambarish Gopal; Naser Ahmadi; Khurram Nasir; Eric Yang; Ioannis Kakadiaris; Ferdinand Flores; Song S Mao; Matthew J Budoff
Journal:  J Am Coll Cardiol       Date:  2008-10-14       Impact factor: 24.094

View more
  2 in total

1.  Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement.

Authors:  Matthew J Budoff; Suvasini Lakshmanan; Peter P Toth; Harvey S Hecht; Leslee J Shaw; David J Maron; Erin D Michos; Kim A Williams; Khurram Nasir; Andrew D Choi; Kavitha Chinnaiyan; James Min; Michael Blaha
Journal:  Am J Prev Cardiol       Date:  2022-01-20

2.  Long-Term Outcomes are Similar Despite Sex Disparities in High-Intensity Statin Use in Patients With Nonobstructive Coronary Artery Disease Diagnosed Via Invasive Coronary Angiography.

Authors:  Edwin Lu; Christopher Hanson; George Beller; Jamieson Bourque
Journal:  J Am Heart Assoc       Date:  2022-02-22       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.